January 9, 2015

Daiichi Sankyo Co., Limited on Friday announced that the Food and Drug Administration has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor that reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. 

 

January 9, 2015

Innovation, the makers of PharmAssist automation solutions for pharmacies, on Friday announced that the Medicine Shoppe pharmacy located in Sherman, Texas, has successfully incorporated a RxSafe 1800 robotic storage and retrieval system. 

 

January 9, 2015

Teva Pharmaceuticals on Friday announced the launch of linezolid injection, the generic equvialent to Zyvox injection from C.P. Pharmaceuticals.

January 9, 2015

Walgreens Boots Alliance on Friday visited the Nasdaq MarketSite in Times Square and rang the Opening Bell.

January 9, 2015

Walgreens Boots Alliance marked its first week as a new public company with the official launch of its new corporate identity — including its new logo and its purpose, vision and values — as set out on its website, walgreensbootsalliance.com.

January 8, 2015

Data from a recent patient satisfaction study conducted by J.D. Power has found that Bayer blood glucose meters ranked highest in overall satisfaction among patients with diabetes.

January 8, 2015

Camber Pharmaceuticals on Thursday announced the launch of valsartan tablets USP in 40-, 80-, 106- and 320-mg dosage strengths.

 

January 8, 2015

Sandoz may be on track to receive the first biosimilar drug approval from the Food and Drug Administration for its Zarxio.

January 8, 2015

Impax Pharmaceuticals on Thursday announced that the U.S. Food and Drug Administration approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.

January 7, 2015

Routine blood pressure testing on PharmaSmart kiosks closely approximates daytime ambulatory blood pressure measurement. 

January 7, 2015

DSN examines three of PricewaterhouseCoopers' "Top Health Industry Issues for 2015" with broad implications for the retail pharmacy industry. 

January 7, 2015

Gloria E. Meredith, dean of the College of Pharmacy and professor of pharmaceutical sciences at Rosalind Franklin University of Medicine and Science in North Chicago, will become the founding dean of Binghamton University’s School of Pharmacy and Pharmaceutical Sciences.

January 7, 2015

With tens and possibly hundreds of billions of dollars in potential savings still snagged in a regulatory limbo, federal lawmakers and health industry stakeholders strongly urged the Food and Drug Administration last month to knock down the final barriers to review and approval of biosimilar drugs for marketing in the United States.

January 7, 2015

Lupin Pharmaceuticals on Tuesday launched its valsartan tablets USP in 40-, 80-, 160- and 320-mg dosage strengths. The drug is the generic version Novartis's Diovan tablets.

January 7, 2015

The pharmaceutical industry is back. Fueled by the launch of expensive, new biotech medicines, rising prices for both branded and generic drugs and a recent slowdown in branded-drug patent expirations and generic competition, the U.S. pharmaceutical market is staging a remarkable resurgence.

January 7, 2015

PipelineRx — a clinical telepharmacy platform company — has acquired Quality Pharmacy Management, which provides remote pharmacy services in six Western states, for an undisclosed amount.

January 7, 2015

Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting such lung-specific diseases as influenza, pneumonia and tuberculosis.

January 7, 2015

Teva Pharmaceutical on Tuesday announced the Food and Drug Administration approved the launch of the company's valsartan tablets, the generic version of Diovan tablets from Novartis. 

 

January 6, 2015

Aurobindo Pharma on Tuesday announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market Valsartan Tablets.

January 6, 2015

Gilead Sciences’ Harvoni and Sovaldi drugs will be exclusive to CVS Health’s Standard Commercial, Exchange (Marketplace), Medicare Part D and Medicaid formularies.

January 6, 2015

Rite Aid named Jocelyn Zazyczny Konrad, currently VP healthcare initiatives, to group VP pharmacy initiatives and clinical services.

 

January 6, 2015

Vermont Attorney General Bill Sorrell is investigating generic drug price inflation.

January 6, 2015

Walgreens on Tuesday announced that December sales increased 10.2% to $7.9 billion.

 

January 6, 2015

According to the Walgreens Flu Index for the week beginning Jan. 5, Knoxville, Tenn. is the No. 1 designated market area with flu activity, followed by the Paducah, Ky. area and Chattanooga, Tenn.